Belgium· BE-AMP-SAM660956-00
Pluvicto 1000 MBq/ml
A lutetium (177lu) vipivotide tetraxetan product containing lutetium (177lu) vipivotide tetraxetan, registered in Belgium by Novartis Europharm. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Lutetium (177lu) vipivotide tetraxetan is registered in 9 of 19 countries.
Countries holding a registration under ATC V10XX05 (lutetium (177lu) vipivotide tetraxetan), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Lutetium (177lu) vipivotide tetraxetan · ATC V10XX05
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lutetium (177Lu) Vipivotide Tetraxetan
- Manufacturer
- Novartis Europharm
- Country
- Belgium (BE)
- ATC code
- V10XX05
- ATC class
- Lutetium (177Lu) vipivotide tetraxetan
- Defined daily dose
- 176 MBq, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4785291
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (177lu) vipivotide tetraxetan in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandPluvicto 1000 MBq/ml, Injektions-/InfusionslösungNovartis Pharma Schweiz AG
- United StatesPLUVICTONovartis Pharmaceuticals Corporation
- FinlandPluvictoNovartis Europharm Limited
- FrancePLUVICTO 1 000 MBq/mL, solution injectable/pour perfusionNOVARTIS EUROPHARM (IRLANDE)
- CanadaPLUVICTONOVARTIS PHARMACEUTICALS CANADA INC
- IrelandPluvicto 1000 MBq/mL solution for injection/infusionNovartis Europharm Limited
- IcelandPluvictoNovartis Europharm Limited*
- NetherlandsPluvicto 1.000 MBq/ml oplossing voor injectie/infusieNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Pluvicto
- Liechtenstein · Pluvicto
- Norway · Pluvicto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff11dadf-2370-48b0-83af-098ae457c6f9 GET /v1/drugs/ff11dadf-2370-48b0-83af-098ae457c6f9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Pluvicto 1000 MBq/ml",
"name_fr": "Pluvicto 1000 MBq/ml",
"name_nl": "Pluvicto 1000 MBq/ml",
"amp_code": "SAM660956-00",
"strengths": [
"1000.0000",
"1000.0000",
"7.1000"
],
"pack_count": 1,
"substances": [
"Lutetium (177Lu) Vipivotide Tetraxetan",
"Sodium"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Lutetium (177Lu) Vipivotide Tetraxetan",
"authorisation_numbers": [
"EU/1/22/1703/001"
]
}See everything about lutetium (177lu) vipivotide tetraxetan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.